|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1-Antitrypsin Alleles in Patients With Bronchiectasis*
* From the Respiratory and Intensive Care Department (Drs. Cuvelier, Muir, and Benhamou), Unité INSERM 295 (Drs. Cuvelier, Martin, and Sesboüé), and the Department of Biostatistics (Drs. Hellot and Bénichou), University Hospital, Rouen, France.
Correspondence to: Antoine Cuvelier, MD, Respiratory and Intensive Care Department, Hôpital de Bois-Guillaume, CHU de Rouen, 76031 Rouen CEDEX, France; e-mail:antoine.cuvelier{at}chu-rouen.fr
Study objectives: Bronchiectasis has been reported in a
few patients with homozygous
1-antitrypsin (AAT)
deficiency, but the distribution of AAT alleles among bronchiectatic
patients is not known.
Patients and design: Two hundred two patients, 104 men and 98 women, with a mean age (SD) of 63.7 ± 15.4 years, had bronchiectasis diagnosed by CT scan alone (n = 178), bronchography with or without CT scan (n = 17), or radiography alone (n = 7). AAT phenotypes (classified according to the protease inhibitor [PI] system) were determined by isoelectric focusing in blood samples obtained from all patients. Bronchiectasis was primary in 121 cases and secondary in 81 patients. Allele and phenotype frequencies were compared retrospectively between bronchiectatic patients and healthy blood donors living in the same geographic area.
Results: The PI phenotype frequencies among patients were the following: MM, 81.18%; MS, 11.88%; MZ, 3.46%; IZ, 0.49%; IM, 0.49%; SS, 1.48%; SZ, 0.49%; and ZZ, 0.49%. The allelic frequencies among patients were the following: M, 89.1%; S, 7.67%; Z, 2.72%; and I, 0.49%. There was no difference in the distribution of alleles or phenotypes either between patients and control subjects or between patients with secondary and primary bronchiectasis. A significant difference was found between bronchiectatic patients with and without coexisting emphysema (p = 0.028). This difference was caused by an overrepresentation of PI*Z alleles in bronchiectatic patients with coexisting emphysema.
Conclusions: Our results do not support a physiopathologic implication of the AAT genes in the development of bronchiectasis. We suggest that bronchiectasis may be a consequence of emphysema in PI*Z patients rather than a primary effect.
Key Words:
1-antitrypsin bronchiectasis COPD emphysema
This article has been cited by other articles:
![]() |
S B Shaker, T Stavngaard, J Stolk, B Stoel, and A Dirksen {alpha}1-Antitrypsin deficiency {middle dot} 7: Computed tomographic imaging in {alpha}1-antitrypsin deficiency Thorax, November 1, 2004; 59(11): 986 - 991. [Abstract] [Full Text] [PDF] |
||||
![]() |
D A Lomas and H Parfrey {alpha}1-Antitrypsin deficiency * 4: Molecular pathophysiology Thorax, June 1, 2004; 59(6): 529 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Needham and R A Stockley {alpha}1-Antitrypsin deficiency * 3: Clinical manifestations and natural history Thorax, May 1, 2004; 59(5): 441 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
American Thoracic Society/European Respiratory Society Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 818 - 900. [Full Text] [PDF] |
||||
![]() |
R A PRIMHAK and M S TANNER Alpha-1 antitrypsin deficiency Arch. Dis. Child., July 1, 2001; 85(1): 2 - 5. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |